A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia.
about
Schizophrenia relapse, patient considerations, and potential role of lurasidoneSpotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depressionLong-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment.Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study.Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders.New perspectives on study designs for evaluating neuroprotection in Parkinson's disease.Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
P2860
Q26738850-6B2FDC1D-3CBD-4725-9EBC-A1602EBDB530Q26747833-BF754044-485E-4B87-95C0-776CC199D974Q37675302-E2EE2FCE-EF6E-43F7-95E5-2BF23A2A6DE8Q41495591-D9115BA0-94A2-40C4-82CC-19C9FF504BD4Q47623090-877406B3-A657-497B-BB76-C17739052D3CQ48133239-3AC0A66E-7A3F-41BD-B0CF-194E1BFF8FFBQ56790547-88413EBD-059B-46D1-ACB5-34F704681749
P2860
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A double-blind, placebo-contro ...... n patients with schizophrenia.
@ast
A double-blind, placebo-contro ...... n patients with schizophrenia.
@en
type
label
A double-blind, placebo-contro ...... n patients with schizophrenia.
@ast
A double-blind, placebo-contro ...... n patients with schizophrenia.
@en
prefLabel
A double-blind, placebo-contro ...... n patients with schizophrenia.
@ast
A double-blind, placebo-contro ...... n patients with schizophrenia.
@en
P2093
P2860
P356
P1476
A double-blind, placebo-contro ...... n patients with schizophrenia.
@en
P2093
Andrei Pikalov
Antony Loebel
David Hernandez
Debra Phillips
Josephine Cucchiaro
Rajiv Tandon
Yongcai Mao
P2860
P356
10.1177/0269881115620460
P407
P577
2015-12-08T00:00:00Z